Related Experiment Video
Updated: Dec 22, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Modulation of mTORC1 Signaling Pathway by HIV-1
Burkitkan Akbay1,2, Anna Shmakova1,2, Yegor Vassetzky1,2,3
1CNRS UMR 9018, Institut Gustave Roussy, Université Paris-Saclay, 114, rue Édouard Vaillant, 94805 Villejuif, France.
Abstract:
Mammalian target of rapamycin complex 1 (mTORC1) is a master regulator of cellular proliferation and survival which controls cellular response to different stresses, including viral infection. HIV-1 interferes with the mTORC1 pathway at every stage of infection. At the same time, the host cells rely on the mTORC1 pathway and autophagy to fight against virus replication and transmission. In this review, we will provide the most up-to-date picture of the role of the mTORC1 pathway in the HIV-1 life cycle, latency and HIV-related diseases. We will also provide an overview of recent trends in the targeting of the mTORC1 pathway as a promising strategy for HIV-1 eradication.
Insights
The mammalian target of rapamycin complex 1 (mTORC1) pathway is crucial for controlling cellular responses to stress and viral infections like HIV-1. Targeting mTORC1 shows promise for eradicating HIV-1 by disrupting its life cycle and related diseases.
Area of Science:
- Cellular Biology
- Virology
- Immunology
Background:
- Mammalian target of rapamycin complex 1 (mTORC1) regulates cell growth, survival, and stress responses.
- HIV-1 infection significantly impacts and hijacks the mTORC1 pathway.
- Host cells utilize mTORC1 and autophagy to combat viral replication and transmission.
Purpose of the Study:
- To review the multifaceted role of the mTORC1 pathway throughout the HIV-1 life cycle.
- To elucidate mTORC1's involvement in HIV-1 latency and associated diseases.
- To explore emerging therapeutic strategies targeting mTORC1 for HIV-1 eradication.
Main Methods:
- Comprehensive literature review of existing research on mTORC1 and HIV-1.
- Analysis of molecular mechanisms underlying mTORC1 pathway interference by HIV-1.
- Synthesis of current findings on mTORC1 targeting for HIV-1 treatment.
Main Results:
- mTORC1 pathway is manipulated by HIV-1 at all infection stages.
- Host cell defense against HIV-1 relies on mTORC1 and autophagy.
- Targeting mTORC1 presents a potential therapeutic avenue for HIV-1.
Conclusions:
- The mTORC1 pathway is a central player in HIV-1 pathogenesis and host response.
- Understanding mTORC1 dynamics is key to developing novel HIV-1 eradication strategies.
- Therapeutic targeting of mTORC1 offers a promising direction for future HIV-1 treatments.
More Related Videos
08:04Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
10:12Author Spotlight: Exploring the Role of Unfolded Protein Response in HIV-1 Replication and Infectivity
Published on: June 14, 2024
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades
Regulation of Angiogenesis and Blood Supply
The JAK-STAT Signaling Pathway